Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Receives Average Recommendation of “Moderate Buy” from Analysts

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANLGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $24.25.

Several research analysts have issued reports on ANL shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. HC Wainwright boosted their price target on shares of Adlai Nortye from $16.00 to $20.00 and gave the company a “buy” rating in a report on Monday, April 20th. JonesTrading began coverage on shares of Adlai Nortye in a research report on Thursday, May 14th. They issued a “buy” rating and a $22.00 price target for the company. Oppenheimer initiated coverage on shares of Adlai Nortye in a research note on Thursday, May 28th. They set an “outperform” rating and a $32.00 price objective on the stock. Finally, Cantor Fitzgerald began coverage on shares of Adlai Nortye in a research note on Monday, June 22nd. They set an “overweight” rating on the stock.

Check Out Our Latest Analysis on Adlai Nortye

Institutional Trading of Adlai Nortye

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. SmartHarvest Portfolios LLC increased its holdings in shares of Adlai Nortye by 8.5% in the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock valued at $113,000 after acquiring an additional 1,279 shares during the period. Renaissance Technologies LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter worth $457,000. Affinity Asset Advisors LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter worth $1,140,000. Finally, ADAR1 Capital Management LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter worth $816,000. Institutional investors own 35.21% of the company’s stock.

Adlai Nortye Stock Performance

Shares of Adlai Nortye stock opened at $13.23 on Tuesday. The stock’s fifty day moving average price is $11.26 and its 200-day moving average price is $10.52. Adlai Nortye has a 12 month low of $0.88 and a 12 month high of $17.25.

About Adlai Nortye

(Get Free Report)

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

See Also

Analyst Recommendations for Adlai Nortye (NASDAQ:ANL)

Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.